跳至主要内容
临床试验/NCT06916858
NCT06916858进行中(未招募)不适用

Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2024年2月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
37
试验地点
1
主要终点
prevalence of OSA in patients with difficult-to-treat asthma

研究概览

简要总结

cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent type 1 in-laboratory polysomnography and type 3 HSAT within 1 month apart

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

盲法说明

mask the result of home sleep test and Polysonography

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •difficult-to-treat asthma .
  • •Patients aged 18 years or older

排除标准

  • •Patients or volunteers unable to undergo type 1 and type 3 sleep studies,
  • •Patients with symptoms compatible with other sleep disorders,
  • •Patients with a history of or current stroke or transient ischemic attack and Other chronic respiratory diseases.
  • •Patients diagnosed with obstructive sleep apnea

研究组 & 干预措施

difficult to treat asthma

Other

difficult to treat asthma run HST and PSG

干预措施: home sleep test (Device)

结局指标

主要结局

prevalence of OSA in patients with difficult-to-treat asthma

时间窗: up to 4 months

prevalence of OSA in patients with difficult-to-treat asthma

次要结局

  • assess the accuracy of type 3 home sleep apnea test (HSAT)(up to 1 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验